Published in Iran J Cancer Prev on August 24, 2015
Effects of Two Common Promoter Polymorphisms of Transforming Growth Factor-β1 on Breast Cancer Risks in Ahvaz, West South of Iran. Iran J Cancer Prev (2016) 0.80
The association of three promoter polymorphisms in interleukin-10 gene with the risk for colorectal cancer and hepatocellular carcinoma: A meta-analysis. Sci Rep (2016) 0.75
Genetic variants in the acylphosphatase 2 gene and the risk of breast cancer in a Han Chinese population. Oncotarget (2016) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer (2014) 40.30
A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res (1991) 6.26
BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer (2004) 6.24
An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet (1997) 5.65
International variation. Oncogene (2004) 4.64
The genetic attributable risk of breast and ovarian cancer. Cancer (1996) 3.55
How many more breast cancer predisposition genes are there? Breast Cancer Res (1999) 3.10
Interleukin-10. Curr Opin Immunol (1992) 2.85
Models of genetic susceptibility to breast cancer. Oncogene (2006) 2.69
Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol (2005) 2.24
Mapping of the human IL10 gene and further characterization of the 5' flanking sequence. Immunogenetics (1997) 1.49
IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. J Immunol (1995) 1.27
Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. Eur J Immunogenet (2004) 1.26
Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience. J Interferon Cytokine Res (1999) 1.13
Increased IL-10 mRNA expression in tumor-associated macrophage correlated with late stage of lung cancer. J Exp Clin Cancer Res (2011) 1.10
Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review. BMC Cancer (2006) 1.09
Interleukin-10 polymorphisms, cancer susceptibility and prognosis. Fam Cancer (2006) 1.08
Association of breast cancer and polymorphisms of interleukin-10 and tumor necrosis factor-alpha genes. Clin Chem (2003) 1.00
Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk. Breast Cancer Res Treat (2005) 0.99
Association of interleukin-10 gene polymorphisms with breast cancer in a Chinese population. J Exp Clin Cancer Res (2010) 0.95
EXProt--a database for EXPerimentally verified Protein functions. In Silico Biol (2002) 0.94
The septic shock-associated IL-10 -1082 A > G polymorphism mediates allele-specific transcription via poly(ADP-Ribose) polymerase 1 in macrophages engulfing apoptotic cells. J Immunol (2010) 0.83
A single-nucleotide polymorphism in tumor necrosis factor-α (-308 G/A) as a biomarker in chronic pancreatitis. Gene (2014) 0.88
A novel insertion-induced frameshift mutation of the androgen receptor gene in a patient with primary amenorrhea. Meta Gene (2013) 0.78
Significant Association of Interleukin4 Intron 3 VNTR Polymorphism with Susceptibility to Gastric Cancer in a South Indian Population from Telangana. PLoS One (2015) 0.76
miRNA regulation during cardiac development and remodeling in cardiomyopathy. EXCLI J (2013) 0.75
BRIP1/FANCJ Mutation Analysis in a Family with History of Male and Female Breast Cancer in India. J Breast Cancer (2017) 0.75
Association of interleukin-10 gene promoter polymorphism in spontaneous abortions: a family-based triad study. Inflamm Res (2015) 0.75
A novel androgen receptor gene mutation in a patient with congenital adrenal hyperplasia associated with penoscrotal hypospadias. Transl Res (2014) 0.75